Martin Everett

Martin Everett oversees AUROBAC’s product pipeline and R&D strategy. With 30+ years in academia, pharma (GSK), and biotech (MerLion, Antabio), he is an expert in antibacterial discovery and antimicrobial resistance. He has authored 30+ peer-reviewed publications and has directed multiple discovery programs, high-throughput screening teams, and natural-product research groups. Martin holds a Ph.D. from the University of Bristol and previously conducted postdoctoral research at the University of Birmingham. At AUROBAC, Martin drives pipeline development and leads all R&D activities.